The SARS-CoV-2 epidemic has caused an unprecedented public health situation and more than ever it is important to be well informed on methods to monitor and analyse the progression of the epidemic. This brief note aims to explain the scope in conducting large-scale serological surveys of SARS-CoV-2 to define the landscape of population immunity, without overlooking the inherent uncertainty steaming from sampling design and diagnostic validity. The note completes with a succinct appendix of simple statistical methods for estimating prevalence from random population samples using imperfect diagnostic tests
Identifying drivers of SARS-CoV-2 exposure and quantifying population immunity is crucial to prepare...
Funder: Oxford University | Jesus College, University of Oxford; doi: https://doi.org/10.13039/50110...
International audienceObjectives: We aimed to review SARS-CoV-2 seroprevalence studies conducted in ...
peer-reviewedSARS-CoV-2 continues to widely circulate in populations globally. Under detection is a...
Well-designed population-based seroepidemiologic studies can be used to refine estimates of infectio...
Purpose: The U.S. response to the SARS-CoV-2 epidemic has been hampered by early and ongoing delays ...
The recent development and regulatory approval of a variety of serological assays indicating the pre...
Background Many studies report the seroprevalence of severe acute respiratory syndrome coronavirus 2...
Updated June 26, 2020Large-scale Geographic Seroprevalence Survey SamplesCommercial Laboratory Surve...
We systematically reviewed the current understanding of human population immunity against SARS-CoV i...
Antibody tests for the novel coronavirus, SARS-CoV2, have been developed both as rapid diagnostic as...
Background The SARS-CoV-2 pandemic has led to the swift introduction of population testing progra...
A critical point in the management of the SARS-CoV-2 pandemic is the need to promptly identify the g...
Properly conducted serological survey can help determine infection disease true spread. This study a...
Funder: Oxford University | Jesus College, University of Oxford; doi: https://doi.org/10.13039/50110...
Identifying drivers of SARS-CoV-2 exposure and quantifying population immunity is crucial to prepare...
Funder: Oxford University | Jesus College, University of Oxford; doi: https://doi.org/10.13039/50110...
International audienceObjectives: We aimed to review SARS-CoV-2 seroprevalence studies conducted in ...
peer-reviewedSARS-CoV-2 continues to widely circulate in populations globally. Under detection is a...
Well-designed population-based seroepidemiologic studies can be used to refine estimates of infectio...
Purpose: The U.S. response to the SARS-CoV-2 epidemic has been hampered by early and ongoing delays ...
The recent development and regulatory approval of a variety of serological assays indicating the pre...
Background Many studies report the seroprevalence of severe acute respiratory syndrome coronavirus 2...
Updated June 26, 2020Large-scale Geographic Seroprevalence Survey SamplesCommercial Laboratory Surve...
We systematically reviewed the current understanding of human population immunity against SARS-CoV i...
Antibody tests for the novel coronavirus, SARS-CoV2, have been developed both as rapid diagnostic as...
Background The SARS-CoV-2 pandemic has led to the swift introduction of population testing progra...
A critical point in the management of the SARS-CoV-2 pandemic is the need to promptly identify the g...
Properly conducted serological survey can help determine infection disease true spread. This study a...
Funder: Oxford University | Jesus College, University of Oxford; doi: https://doi.org/10.13039/50110...
Identifying drivers of SARS-CoV-2 exposure and quantifying population immunity is crucial to prepare...
Funder: Oxford University | Jesus College, University of Oxford; doi: https://doi.org/10.13039/50110...
International audienceObjectives: We aimed to review SARS-CoV-2 seroprevalence studies conducted in ...